http://articles.mercola.com/sites/articles/archive/2001/10/20/infliximab.aspxInfliximab, an immune-suppressing drug used to treat rheumatoid arthritis and Crohn's disease, is behind 70 reported cases of tuberculosis (TB) among U.S. patients who received the medication. The cases, at least four of which were fatal, were reportedenCommunityServer 2008.5 SP1 (Build: 31106.3070)